Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-034820

Director bought 84 shares at an average $4.80 ($404)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Caroline Director 2025-06-02 Purchase 10b5-1 +4 $5.20 $21 32,573 D
Young Caroline Director 2025-06-03 Purchase 10b5-1 +4 $5.61 $22 32,577 D
Young Caroline Director 2025-06-04 Purchase 10b5-1 +4 $5.75 $23 32,581 D
Young Caroline Director 2025-06-05 Purchase 10b5-1 +4 $5.46 $22 32,585 D
Young Caroline Director 2025-06-06 Purchase 10b5-1 +4 $5.57 $22 32,589 D
Young Caroline Director 2025-06-09 Purchase 10b5-1 +4 $5.94 $24 32,593 D
Young Caroline Director 2025-06-10 Purchase 10b5-1 +4 $6.00 $24 32,597 D
Young Caroline Director 2025-06-11 Purchase 10b5-1 +4 $5.57 $22 32,601 D
Young Caroline Director 2025-06-12 Purchase 10b5-1 +4 $5.67 $23 32,605 D
Young Caroline Director 2025-06-13 Purchase 10b5-1 +4 $5.81 $23 32,609 D
Young Caroline Director 2025-06-16 Purchase 10b5-1 +4 $5.32 $21 32,613 D
Young Caroline Director 2025-06-17 Purchase 10b5-1 +4 $5.61 $22 32,617 D
Young Caroline Director 2025-06-18 Purchase 10b5-1 +4 $5.52 $22 32,621 D
Young Caroline Director 2025-06-20 Purchase 10b5-1 +4 $5.29 $21 32,625 D
Young Caroline Director 2025-06-23 Purchase 10b5-1 +4 $4.61 $18 32,629 D
Young Caroline Director 2025-06-24 Purchase 10b5-1 +4 $3.91 $16 32,633 D
Young Caroline Director 2025-06-25 Purchase 10b5-1 +4 $3.27 $13 32,637 D
Young Caroline Director 2025-06-26 Purchase 10b5-1 +4 $2.71 $11 32,641 D
Young Caroline Director 2025-06-27 Purchase 10b5-1 +4 $2.60 $10 32,645 D
Young Caroline Director 2025-06-30 Purchase 10b5-1 +8 $2.74 $22 32,653 D
Open-market purchases · 84 sh · avg $4.80 · $404
Loading xslF345X05/wk-form4_1752270634.xml…